Why confidence intervals are useful tools in clinical therapeutics

Impact of 2,4-diacetylphloroglucinol-producing biocontrol strain Pseudomonas fluorescens F113 on intraspecific diversity of resident culturable fluorescent pseudomonads associated with the roots of field-grown sugar beet seedlings.

Applied and environmental microbiology·2001

Comparative strain typing of Rhizobium leguminosarum bv. viciae natural populations.

Canadian journal of microbiology·2001

Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome.

Medical and pediatric oncology·2001

Control of cell fate in plant meristems.

Novartis Foundation symposium·2001

A molecular link between stem cell regulation and floral patterning in Arabidopsis.

Cell·2001

Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes.

Cancer research·2001

An integrated methodological roadmap for real-world biomarker studies: advancing oncology precision medicine through robust methodologies and machine learning integration.

Journal of biopharmaceutical statistics·2026

Randomization-based covariance analysis for hypothesis testing of treatment comparisons based on restricted mean survival time with categorized time-to-event data.

Journal of biopharmaceutical statistics·2026

A phase II, seamless single-arm to two-arm Bayesian design for a time-to-event endpoint.

Journal of biopharmaceutical statistics·2026

Balancing sample size and accuracy of dose selection in phase 1 oncology trials - designs tiered by cohort size and maximum number of patients treated per dose.

Journal of biopharmaceutical statistics·2026

Why the minimum effective dose is unidentifiable - and how a DOR→OOD standard delivers label-ready dosing in oncology.

Journal of biopharmaceutical statistics·2026

Augmented match weighted estimators: new methods for estimating average treatment effects under extreme propensity scores.

Journal of biopharmaceutical statistics·2026

Utilization patterns of second-generation androgen receptor pathway inhibitors as first-line therapy for prostate cancer in the United States.

Prostate cancer and prostatic diseases·2026

Progress on novel compounds for the treatment of bone metabolism-related disorders: focus on osteoporosis and beyond.

Frontiers in chemistry·2026

Clinical Approach to Impulse Control-Related Behavioral Disorders in Parkinson's Disease: A Scoping Review.

Movement disorders clinical practice·2026

Prescribing and monitoring of riluzole in amyotrophic lateral sclerosis: a retrospective cohort study from Health New Zealand - Te Whatu Ora Waitaha Canterbury.

The New Zealand medical journal·2026

Researchers struggle to improve nonopioid pain drugs.

Science (New York, N.Y.)·2026

Patterns and Trends in Vasoactive Medication Use in Patients With Pulmonary Arterial Hypertension Presenting With Shock.

Pulmonary circulation·2026

Related Experiment Videos

Why confidence intervals are useful tools in clinical therapeutics

Related Concept Videos

Impact of 2,4-diacetylphloroglucinol-producing biocontrol strain Pseudomonas fluorescens F113 on intraspecific diversity of resident culturable fluorescent pseudomonads associated with the roots of field-grown sugar beet seedlings.

Comparative strain typing of Rhizobium leguminosarum bv. viciae natural populations.

Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome.

Control of cell fate in plant meristems.

A molecular link between stem cell regulation and floral patterning in Arabidopsis.

Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes.

An integrated methodological roadmap for real-world biomarker studies: advancing oncology precision medicine through robust methodologies and machine learning integration.

Randomization-based covariance analysis for hypothesis testing of treatment comparisons based on restricted mean survival time with categorized time-to-event data.

A phase II, seamless single-arm to two-arm Bayesian design for a time-to-event endpoint.

Balancing sample size and accuracy of dose selection in phase 1 oncology trials - designs tiered by cohort size and maximum number of patients treated per dose.

Why the minimum effective dose is unidentifiable - and how a DOR→OOD standard delivers label-ready dosing in oncology.

Augmented match weighted estimators: new methods for estimating average treatment effects under extreme propensity scores.

Utilization patterns of second-generation androgen receptor pathway inhibitors as first-line therapy for prostate cancer in the United States.

Progress on novel compounds for the treatment of bone metabolism-related disorders: focus on osteoporosis and beyond.

Clinical Approach to Impulse Control-Related Behavioral Disorders in Parkinson's Disease: A Scoping Review.

Prescribing and monitoring of riluzole in amyotrophic lateral sclerosis: a retrospective cohort study from Health New Zealand - Te Whatu Ora Waitaha Canterbury.

Researchers struggle to improve nonopioid pain drugs.

Patterns and Trends in Vasoactive Medication Use in Patients With Pulmonary Arterial Hypertension Presenting With Shock.

Related Experiment Videos

Why confidence intervals are useful tools in clinical therapeutics

Related Concept Videos

Related Articles